Abstract:The mechanistic target of rapamycin complex 1 (mTORC1) is an important intracellular energy sensor that regulates protein synthesis through its downstream signaling components the S6‐kinase and the ribosomal S6 protein. Recently, our laboratory has demonstrated a critical role of the mTORC1 signaling pathway in the cardiovascular regulation with implications for obesity and hypertension. In this study, we tested the hypothesis that the mTORC1 signaling pathway in the vasculature is involved in the regulation of vascular endothelial function and that dysregulation of this pathway contributes to the cardiovascular disorders associated with obesity. We began by assessing the effects of activating mTORC1 signaling in cultured mouse lung endothelial cells (MLECs) using leucine (10 mM; 16hrs) or a constitutively active S6‐kinase adenoviral construct (Ad‐S6KCA; 48hrs). Activated mTORC1 signaling was confirmed by the increased phosphorylated levels of the ribosomal S6 protein (2–4 fold; p<0.05). Increasing mTORC1 signaling elevated mRNA expression of oxidative stress markers (NOX1 and NOX2; 1.5–5 fold; p<0.05), decreased mRNA expression of superoxide dismutase 2 (0.5 fold; p<0.05) and increased reactive oxygen species (ROS) generation (via dihydroethidium staining; 1.5 fold; p<0.05) in MLECs demonstrating a pro‐oxidant gene environment evoked by activation of mTORC1 signaling. Blockade of the IKKβ subunit of the NFκB transcriptional complex (BMS‐345541; 300nM) prevented mTORC1 signaling induced ROS generation in MLECs demonstrating a critical role of NFκB signaling in the cellular response to mTORC1 activation. Next, we used leucine and Ad‐S6KCA to test the consequence of enhancing mTORC1 signaling on endothelial function in aortic rings isolated from wildtype mice. Both leucine and an adenovirus expressing a constitutively active form of S6K (Ad‐S6KCA) impaired endothelial dependent acetylcholine‐induced relaxation (~10–15%; p<0.05) without changing endothelial‐independent relaxation responses evoked by sodium nitroprusside indicating endothelial but not smooth muscle dysfunction in response to increased mTORC1 signaling. Blockade of mTORC1 signaling using a dominant negative S6K adenoviral construct (Ad‐S6KDN) as well as inhibition of ROS signaling by Tempol (non‐specific free radical scavenger) ameliorated mTORC1‐induced endothelial dysfunction (p<0.05). To determine the involvement of mTORC1 signaling in the endothelial dysfunction associated with obesity, we utilized diet‐induced obese mice that display vascular endothelial dysfunction as compared to lean controls. Obese mice exhibited increased mTORC1 signaling in the aorta and mesenteric artery indicated by the elevated phosphorylated levels of the ribosomal S6 protein (1.5–3 fold; p<0.05) and this was associated with increases in NOX2 expression (1.5 fold; p<0.05) further indicating ROS signaling in the vascular pathology associated with obesity. We conclude that mTORC1 signaling is a novel regulator of vascular endothelial function through its effects on the NFκB complex and ROS signaling. Our data also indicate that dysregulation of the mTORC1 signaling pathway may be involved in the endothelial dysfunction associated with obesity.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Down regulation of Peroxiredoxin-3 in 3T3-L1 adipocytes leads to oxidation of Rictor in the mammalian-target of rapamycin complex 2 (mTORC2)

Adipose Tissue-Specific PPARγ Deficiency Increases Resistance to Oxidative Stress

Depletion of Prmt1 in Adipocytes Impairs Glucose Homeostasis in Diet-Induced Obesity

Peroxiredoxin1: a Potential Obesity-Related Factor in the Hypothalamus.

Abstract P209: Mechanistic Target of Rapamycin Complex 1 (mtorc1) Signaling Generates Reactive Oxygen Species in Mouse Endothelial Cells Via NFkB Signaling

Mitochondrial-generated ROS down regulates insulin signaling via activation of the p38MAPK stress response pathway

Adipocyte-specific deletion of Depdc5 exacerbates insulin resistance and adipose tissue inflammation in mice

PRDX1 is Involved in Palmitate Induced Insulin Resistance Via Regulating the Activity of P38mapk in HepG2 Cells

Diabetic Downregulation of Nrf2 Activity Via Erk Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells in Vitro and in Vivo

Deletion of PRAK Mitigates the Mitochondria Function and Suppresses Insulin Signaling in C2C12 Myoblasts Exposed to High Glucose

Mtorc1 Signaling Regulates Vascular Endothelial Function Via Reactive Oxygen Species and NFκB Signaling

Hypoxia in 3T3-L1 Adipocytes Suppresses Adiponectin Expression Via the PERK and IRE1 Unfolded Protein Response.

Activation of the ROS/TXNIP/NLRP3 pathway disrupts insulin-dependent glucose uptake in skeletal muscle of insulin-resistant obese mice

Bidirectional Modulation of Insulin Action by Reactive Oxygen Species in 3T3‑L1 Adipocytes.

Sirt3 Deficiency Increased the Vulnerability of Pancreatic Beta Cells to Oxidative Stress-Induced Dysfunction

Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice

Mammalian Target of Rapamycin Signaling Pathway Regulates Mitochondrial Quality Control of Brown Adipocytes in Mice

Abstract 080: Mtorc1 As a Novel Regulator of Vascular Endothelial Function in Obese Mice and Humans

(3 AR-mTOR-lipin1 Pathway Mediates PKA-RII(3 (3 Deficiency-Induced Adipose Browning

Activation of the Ampk-Foxo3 Pathway Reduces Fatty Acid-Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin

Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism